Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer

被引:9
|
作者
Kim, Dohun [1 ]
Choi, Yong Soo [1 ]
Kim, Hong Kwan [1 ]
Kim, Kwhanmien [2 ]
Kim, Jhingook [1 ]
Shim, Young Mog [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Thorac Surg, Samsung Med Ctr, Seoul 135710, South Korea
[2] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Thorac Surg, Seoul, South Korea
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2014年 / 62卷 / 02期
关键词
lung cancer; diagnosis (includes staging; imaging; and fiducial); lung cancer treatment (surgery and medicine); positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LYMPH-NODE INVOLVEMENT; PROGNOSTIC-SIGNIFICANCE; STAGING PROJECT; FDG-PET; CT; CLASSIFICATION; ACCURACY;
D O I
10.1055/s-0032-1333067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThere have been many reports of N1 node metastasis on computed tomography (CT) scan, but not on positron emission tomography (PET)-CT in nonsmall cell lung cancer. The aim of this study was to analyze the clinicopathologic correlation and survival of N1 disease on preoperative PET-CT. MethodsFrom January 2003 to December 2007, 1,748 curative lung resections were performed at a single institute. We enrolled 91 patients with clinical N1 on PET-CT. All the enrolled patients had undergone pulmonary resection with mediastinal lymph node dissection. According to the preoperative PET-CT, we classified the patients into two groups: those with single N1 metastasis (cN1a, n=91) and those with multiple N1 metastases (cN1b, n=8). Clinicopathologic N staging was compared and survival analysis was performed. ResultsPathologic N2 was found in 19 (19%) patients and was more common in cN1b (4 of 8) than in cN1a group (15 of 91) (p=0.042). Overall or disease-free survival rate was not different between cN1a and cN1b in the pathologic non-N2 (p=0.723, 0.905) or in pathologic N2 (p=0.954, 0.607) subgroups. ConclusionClinical N1 on PET-CT is heterogeneous in its pathologic staging and multiple clinical N1 is more related to pathologic N2 than single clinical N1. More cases are needed to show the prognostic significance of multiple clinical N1-pathologic N2.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [31] Standard Mediastinoscopy Versus Video-Assisted Mediastinoscopic Lymphadectomy in Clinical N1 Non-Small Cell Lung Cancer
    Turna, A.
    Melek, H.
    Kara, H. V.
    Kilic, B.
    Kaynak, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S848 - S848
  • [32] Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer
    Fukui, Takayuki
    Kato, Katsuhiko
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukumoto, Koichi
    Nakamura, Shota
    Hakiri, Shuhei
    Ozeki, Naoki
    Yokoi, Kohei
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2017, 65 (11) : 640 - 645
  • [33] Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer
    Takayuki Fukui
    Katsuhiko Kato
    Toshiki Okasaka
    Koji Kawaguchi
    Koichi Fukumoto
    Shota Nakamura
    Shuhei Hakiri
    Naoki Ozeki
    Kohei Yokoi
    [J]. General Thoracic and Cardiovascular Surgery, 2017, 65 : 640 - 645
  • [34] Phase I study of N1,N11-diethylnorspermine in patients with non-small cell lung cancer
    Hahm, HA
    Ettinger, DS
    Bowling, K
    Hoker, B
    Chen, TL
    Zabelina, Y
    Casero, RA
    [J]. CLINICAL CANCER RESEARCH, 2002, 8 (03) : 684 - 690
  • [35] Clinicopathologic correlates of postoperative N1 or N2 nodal upstaging in non-small cell lung cancer
    Moon, Youngkyu
    Lee, Kyo Young
    Kim, Kyung Soo
    Park, Jae Kil
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (01) : 79 - 85
  • [36] Prognostic Significance of Urine N1,N12-Diacetylspermine in Patients with Non-small Cell Lung Cancer
    Kato, Masato
    Onishi, Hideya
    Matsumoto, Kotaro
    Motoshita, Junichi
    Tsuruta, Nobuko
    Higuchi, Kazuyuki
    Katano, Mitsuo
    [J]. ANTICANCER RESEARCH, 2014, 34 (06) : 3053 - 3059
  • [37] Clinical utility of endobronchial ultrasound-guided transbronchial needle aspiration in clinical N1 non-small cell lung cancer patients
    Kim, Bo-Guen
    Shin, Sun Hye
    Yoo, Hongseok
    Lee, Kyungjong
    Um, Sang-Won
    Kim, Hojoong
    Cho, Jong Ho
    Kim, Jhingook
    Shim, Young Mog
    Jeong, Byeong-Ho
    [J]. RESPIROLOGY, 2023, 28 : 51 - 51
  • [38] Clinical significance of aminopeptidase N in non-small cell lung cancer
    Tokuhara, Takahiro
    Hattori, Noboru
    Ishida, Hisao
    Hirai, Tatsuya
    Higashiyama, Masahiko
    Kodama, Ken
    Miyake, Masayuki
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (13) : 3971 - 3978
  • [39] Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer
    Robinson, Eric M.
    Ilonen, Ilkka K.
    Tan, Kay See
    Plodkowski, Andrew J.
    Bott, Matthew
    Bains, Manjit S.
    Adusumilli, Prasad S.
    Park, Bernard J.
    Rusch, Valerie W.
    Jones, David R.
    Huang, James
    [J]. ANNALS OF THORACIC SURGERY, 2020, 109 (01): : 270 - 276
  • [40] Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease
    Smithy, James W.
    Rosen, Joshua E.
    Gao, Sarah J.
    Kim, Anthony W.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 1193 - 1196